KUPPUSWAMY JAGARLAMUDI: Open Payments
NPI 1194995357 · MATTOON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,965 in 137 payments from 28 companies in 2025. Trend: 2023 $3,079 · 2024 $3,415 · 2025 $2,965
Food & beverage: $2,481Education: $484
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $462 |
| Novartis Pharmaceuticals Corporation | 29 | $394 |
| Janssen Biotech, Inc. | 13 | $317 |
| Merck Sharp & Dohme LLC | 9 | $196 |
| E.R. Squibb & Sons, L.L.C. | 9 | $142 |
| Lilly USA, LLC | 3 | $129 |
| Aveo Pharmaceuticals, Inc. | 2 | $126 |
| Astellas Pharma US Inc | 5 | $126 |
| Daiichi Sankyo Inc. | 4 | $106 |
| Incyte Corporation | 1 | $99 |
Products named: KEYTRUDA, LYNPARZA, RYBREVANT, IMFINZI, KISQALI, Fabhalta, FOTIVDA, ENHERTU.
Industry payments across IL — which companies pay providers there.
